Two types of Excedrin items has temporarily been discontinued as a precautionary measure said Pharmaceutical company GlaxoSmithKline.
The company has suspended production and distribution of its Excedrin Extra Strength and Excedrin Migraine products.
“Through routine quality control and assurance measures, we discovered inconsistencies in how we transfer and weigh ingredients for Excedrin Extra Strength Caplets and Geltabs, and Excedrin Migraine Caplets and Geltabs,” it said in a statement to CNN.
The company said they do not believe that the product poses a risk to consumers but has chosen to implement the measure out of precaution.
“Other Excedrin products are available along with other pain-relieving drugs, but dosages may differ. Consumers should consult their pharmacist for the most suitable alternative product.”
The company described it as a short term issue, saying it expects production to resume shortly.
Some drugstores are reporting shortages of Excedrin products as a result.
Photo: Mike Mozart
